Abstract
Purpose
To summarise the causes of decreased fecundity with age and review chronological vs biological ovarian ageing. To explore the clinician’s means of assessing a woman’s ovarian reserve. To review the recent literature on the effectiveness of different assisted reproductive technology (ART) techniques for women aged 40 and over and offer a single best treatment option.
Methods
Pubmed and google scholar were searched for relevant articles using key words. Data were extracted based on authors, year, aims, sample and results.
Results
Success rates for women aged 40 or over with clomiphene, IUI, IUI with FSH are all extremely low, at less than 1 % live birth per cycle. However, IVF offers a success rate of around 13.7 % per cycle.
Conclusion
An exploration of the effectiveness of available treatment options for older infertile women using their own gametes suggests that IVF offers the best prospects of success. Attempting treatments other than IVF will delay conception unnecessarily.
Similar content being viewed by others
References
Botting B, Dunnell K. Trends in fertility and contraception in the last quarter of the 20th century. Popul Trends. 2010;100:32–9.
Bewley S, Davies M, Braude P. Which career first? BMJ. 2005;331:588–9.
Stein Z, Susser M. The risks of having children in later life. BMJ. 2000;320:1681–2.
Maheshwari A, Hamilton M, Bhattacharya S. Effect of female age on the diagnostic categories of infertility. Hum Reprod. 2008;23(3):538–42.
Balasch J. Investigation of the infertile couple: investigation of the infertile couple in the era of assisted reproduction technology: a time for reappraisal. Hum Reprod. 2000;15:2251–7.
Howles CM, Kim CH, Elder K. Treatment strategies in assisted reproduction for women of advanced maternal age. Int Surg. 2006;91(5 Suppl):S37–54.
Menken J, Trussell J, Larsen U. Age and infertility. Science. 1986;233:1389–94.
ESHRE Capri Workshop Group. Fertility and ageing. Hum Reprod Updat. 2005;11:261–76.
Kline J, Stein Z, Susser M. Conception to birth. New York: Oxford University Press; 1989. p. 259–94.
Marcus S, Brinsden P. In-vitro fertilization and embryo transfer in women aged 40 years and over. Hum Reprod Updat. 1996;2(6):459–68.
Magarelli C, Pearlstone C, Buyalos R. Discrimination between chronological and ovarian age in infertile women aged 35 years and older: predicting pregnancy using basal follicle stimulating hormone, age and number of ovulation induction/intra-uterine insemination cycles. Hum Reprod. 1996;11(6):1214–9.
Lobo RA. Early ovarian ageing: a hypothesis. What is early ovarian ageing? Hum Reprod. 2003;18:1762–4.
Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7:1342–6.
Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008;23:699–708.
Johnson NP, Bagrie EM, Coomarasamy A, Bhattacharya S, Shelling AN, Jessop S. Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology: the International Systematic Collaboration of Ovarian Reserve Evaluation protocol for a systematic review of ovarian reserve test accuracy. BJOG. 2006;113:1472–80.
Navot D, Bergh PA, Williams MA, et al. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet. 1991;337:1375–7.
Akande VA, Fleming CF, Hunt LP, Keay SD, Jenkins JM. Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum Reprod. 2002;17(8):101–6.
Alviggi C, Humaidan P, Howles CM, Tredway D, Hillier SG. Biological versus chronological ovarian age: implications for assisted reproductive technology. Reprod Biol Endocrinol. 2009;7:101.
Scott RT et al. Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;51:651–4.
Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Updat. 2006;12:685–718.
Nelson SM, Yates RW, Fleming R. Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles—implications for individualization of therapy. Hum Reprod. 2007;22:2414–21.
La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artensio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Updat. 2010;16:113–30.
Kelsey TW, Anderson RA, Wright P, Nelson SM, Wallace WHB. Data-driven assessment of the human ovarian reserve. Mol Hum Reprod. 2012;18(2):79–87.
Bhide P, Gudi A, Shah A, Timms P, Grayson K, Homburg R. Anti-Mullerian hormone as a predictor of pregnancy following IVF. Reprod BioMed Online. 2013;26:247–52.
Tsafrir A, Simon A, Margalioth E, Laufer N. What should be the first-line treatment for unexplained fertility in women over 40 years of age—ovulation induction and IUI or IVF? Reprod BioMed Online; www.rbmonline.com/Article/4334 on web 15 Sept 2009.
Guzick DS, Sullivan MW, Adamson GD. Efficacy of treatment for unexplained fertility. Fertil Steril. 1998;70:207–13.
Bhattacharya S, Harrild K, Mollison J. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomized controlled trial. Br Med J. 2008;337:716.
Corsan G, Trias A, Trout S, Kemmann E. Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile? Hum Reprod. 1996;11(5):1109–12.
Dovey S, Sneeringer R, Penzias A. Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles. Fertil Steril. 2008;90(6):2281–6.
Liu K, Case A, Saskatoon SK. Advancing reproductive age and fertility. Int J Gynaecol Obstet. 2011;117:95–102.
Haebe J, Martin J, Tekepety F, Tummon I, Shepherd K. Success of intrauterine insemination in women aged 40–42 years. Fertil Steril. 2002;78(1):29–33.
Merviel P, Heraud MH, Grenier N, Lourdel E, Sanguinet P, Copin H. Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1038 cycles and a review of the literature. Fertil Steril. 2010;93(1):79–88.
Andersen et al. Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Hum Reprod. 2008;23(4):756–71.
Pandian Z, Gibreel AF, Bhattacharya S. In-vitro fertilization for unexplained subfertilty. Cochrane Libr 2010; Issuee 11.
Nyboe et al. Assisted Reproductive technology and intrauterine inseminations in Europe 2005: results generated from European registers by ESHRE. Hum Reprod. 2009;24:1267–87.
ESHRE Capri workshop group 2009. Intrauterine insemination. Hum Reprod Updat. 2009;15:265–77.
Human Fertilisation and Embryology Authority (HFEA). Fertility treatment in 2010: trends and figures. London: HFEA; 2010. www.hfea.gov.uk/104.html.
Moragianni V, Penzias A. Cumulative live-birth rates after assisted reproductive technology. Curr Opin Obstet Gynecol. 2010;22:189–92.
Wiser A et al. Ovarian stimulation and intrauterine insemination in women aged 40 years or more. Reprod BioMed Online. 2012;24:170–3.
Author information
Authors and Affiliations
Corresponding author
Additional information
Capsule
The single best treatment option for infertile women = 40, using their own gametes, is IVF. Trying other fertility treatments will delay the chance of conceiving unnecessarily.
Rights and permissions
About this article
Cite this article
Armstrong, S., Akande, V. What is the best treatment option for infertile women aged 40 and over?. J Assist Reprod Genet 30, 667–671 (2013). https://doi.org/10.1007/s10815-013-9980-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-013-9980-6